Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression

Fig. 1

Immunoexpression of luminal and basal markers in the bladder cancer cohort. a, b FOXA1 strong and diffuse immunoexpression in two bladder cancer specimens, one NMIBC (a) and one MIBC (b); c, d: GATA3 strong and diffuse immunoexpression in two bladder cancer specimens, one NMIBC (c) and one MIBC (d); e, f: CK5/6 strong multifocal immunoexpression in two bladder cancer specimens, one NMIBC (e) and one MIBC (f)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us